SCHEMBL631719

SCHEMBL631719

CC(C)(C)OC(=O)NCCNCCNC(=O)OC(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.60
MEN1 O00255 1/20 0.56
GAA P10253 1/20 0.56
KMT2A Q03164 1/20 0.56
MAOA P21397 1/20 0.56
MAOB P27338 1/20 0.56
EPHX1 P07099 1/20 0.53
CA12 O43570 6/20 0.49
CA1 P00915 6/20 0.49
CA2 P00918 6/20 0.49
CA9 Q16790 6/20 0.49
MALT1 Q9UDY8 1/20 0.45
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
BCHE P06276 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GFER P55789 1/20 0.43
IDO1 P14902 1/20 0.42
NQO2 P16083 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20801639 1.00 TDP1 (0.60) TDP1MEN1GAAKMT2AMAOA
SCHEMBL9998912 1.00 TDP1 (0.60) TDP1MEN1GAAKMT2AMAOA
SCHEMBL3341020 0.93 TDP1 (0.67) TDP1MEN1GAAKMT2AMAOA
SCHEMBL18614971 0.92 MEN1 (0.54) TDP1MEN1GAAKMT2AMAOA
SCHEMBL10050115 0.92 TDP1 (0.53) TDP1MEN1GAAKMT2AMAOA
SCHEMBL19646831 0.92 TDP1 (0.62) TDP1MEN1GAAKMT2AMAOA
SCHEMBL13247413 0.92 MAOA (0.63) TDP1MEN1GAAKMT2AMAOA
SCHEMBL10050077 0.92 TDP1 (0.53) TDP1MEN1GAAKMT2AMAOA
SCHEMBL24485691 0.90 TDP1 (0.51) TDP1MEN1GAAKMT2AMAOA
SCHEMBL1307836 0.90 MAOA (0.57) TDP1MEN1GAAKMT2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119683891-B Anti-cracking admixture for mass concrete and application thereof 中交四航局第一工程有限公司 2025-05-09 CN claimed
CN-117757023-B High-salt low-permeability oil reservoir oil displacement agent containing betaine type surfactant and preparation method thereof 西安石油大油气科技有限公司 2025-04-29 CN claimed
CN-119683891-A Anti-cracking admixture for mass concrete and application thereof 中交四航局第一工程有限公司 2025-03-25 CN claimed
CN-118272016-B Aldehyde-free adhesive for artificial boards and preparation method 大洼县兰田化工有限公司 2024-11-19 CN claimed
CN-118420812-B Preparation method of porous adsorption resin for treating high-salt high-ammonia-nitrogen wastewater and metal wastewater 辽宁科技学院 2024-10-29 CN claimed
CN-118725191-A Temperature-resistant polyacrylamide resistance reducing agent and preparation method and application thereof 新疆力科石油化工技术服务有限公司 2024-10-01 CN claimed
CN-118420812-A Preparation method of porous adsorption resin for treating high-salt high-ammonia-nitrogen wastewater and metal wastewater 辽宁科技学院 2024-08-02 CN claimed
CN-118272016-A Aldehyde-free adhesive for artificial boards and preparation method 大洼县兰田化工有限公司 2024-07-02 CN claimed
CN-117757023-A High-salt low-permeability oil reservoir oil displacement agent containing betaine type surfactant and preparation method thereof 西安石油大油气科技有限公司 2024-03-26 CN claimed
CN-115491089-B Modified carbon nano tube-fluorocarbon resin and application thereof in wear-resistant aluminum veneers 山东海天七彩建材有限公司 2023-10-27 CN claimed
CN-116355196-A Preparation process and application of hyperbranched polyether surfactant 浙江辽想新材料科技有限公司 2023-06-30 CN claimed
CN-115491089-A Modified carbon nano tube-fluorocarbon resin and application thereof in wear-resistant aluminum veneer 山东海天七彩建材有限公司 2022-12-20 CN claimed
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 EP disclosed
US-20260083854-A1 CONJUGATES COMPRISING BIS-MSPT LINKER LILLY CO ELI (US) 2026-03-26 US disclosed
EP-3915587-B1 IMPROVED CELL-TARGETING BINDING MOLECULE SAPREME TECH BV (NL) 2026-03-25 EP disclosed
US-20260061065-A1 ANTIBODY DRUG CONJUGATES NOVARTIS AG (CH) 2026-03-05 US disclosed
WO-2001055111-A1 BIARYL COMPOUNDS, THEIR PREPARATION AND THEIR USE IN THERAPY RIBOTARGETS LIMITED (GB) 2001-08-02 WO disclosed
WO-2000039055-A1 RAPID PURIFICATION BY POLYAROMATIC QUENCH REAGENTS WARNER-LAMBERT COMPANY (US) 2000-07-06 WO disclosed
EP-0279307-B2 Bifunctional chelating agents ABBOTT LAB (US) 1996-11-13 EP disclosed
EP-0308757-B1 MULTIDENTATE CHELATORS BASED ON THE 8-HYDROXYQUINOLINE UNIT ABBOTT LABORATORIES (US) 1993-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083854-A1 CONJUGATES COMPRISING BIS-MSPT LINKER TFRC, TNFSF11, FTH1 TDP1 4742/4885MEN1 3748/4885GAA 3171/4885
US-20260061065-A1 ANTIBODY DRUG CONJUGATES FCGR2A, FCGR3B, BCL3 TDP1 1610/4885MEN1 4097/4885GAA 2297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.